FI891528L - Antikroppheterokonjugat foer anvaendning vid reglering av lymfocytaktivitet. - Google Patents

Antikroppheterokonjugat foer anvaendning vid reglering av lymfocytaktivitet. Download PDF

Info

Publication number: FI891528L
Authority: FI; Finland
Prior art keywords: lymphocytaktivitet; antikropheterokonjugat; reglering; foer anvaendning; anvaendning vid
Prior art date: 1988-04-04

Application number

FI891528A

Other languages

English (en)

Other versions

FI105320B (fi

FI891528A0 (fi

Inventor

Jeffrey A Ledbetter

Original Assignee

Oncogen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-04-04

Filing date

1989-03-30

Publication date

1989-10-05

1989-03-30 Application filed by Oncogen filed Critical Oncogen

1989-03-30 Publication of FI891528A0 publication Critical patent/FI891528A0/fi

1989-10-05 Publication of FI891528L publication Critical patent/FI891528L/fi

2000-07-31 Application granted granted Critical

2000-07-31 Publication of FI105320B publication Critical patent/FI105320B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2806—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2812—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2815—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2818—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD28 or CD152
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD45
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Mycology (AREA)
Virology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Spinning Or Twisting Of Yarns (AREA)
Coating With Molten Metal (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

FI891528A 1988-04-04 1989-03-30 Menetelmä vasta-aineheterokonjugaattien valmistamiseksi, joita käytetään imusoluaktiivisuuden säätelyssä ja diagnoosissa FI105320B (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US17682588A	1988-04-04	1988-04-04
US17682588		1988-04-04
US27193488A	1988-11-14	1988-11-14
US27193488		1988-11-14

Publications (3)

Publication Number	Publication Date
FI891528A0 FI891528A0 (fi)	1989-03-30
FI891528L true FI891528L (fi)	1989-10-05
FI105320B FI105320B (fi)	2000-07-31

Family

ID=26872636

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI891528A FI105320B (fi)	1988-04-04	1989-03-30	Menetelmä vasta-aineheterokonjugaattien valmistamiseksi, joita käytetään imusoluaktiivisuuden säätelyssä ja diagnoosissa

Country Status (20)

Country	Link
EP (1)	EP0336379B1 (fi)
JP (1)	JP2613106B2 (fi)
KR (1)	KR100205833B1 (fi)
CN (1)	CN1058296C (fi)
AT (1)	ATE133866T1 (fi)
AU (1)	AU629204B2 (fi)
DE (1)	DE68925593T2 (fi)
DK (1)	DK173382B1 (fi)
ES (1)	ES2083960T3 (fi)
FI (1)	FI105320B (fi)
GR (1)	GR3019224T3 (fi)
HU (1)	HU213576B (fi)
IE (1)	IE72187B1 (fi)
IL (1)	IL89823A (fi)
MY (1)	MY106592A (fi)
NO (1)	NO178699C (fi)
NZ (1)	NZ228560A (fi)
PT (1)	PT90195B (fi)
YU (1)	YU68589A (fi)
ZA (1)	ZA892448B (fi)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5846799A (en) *	1988-06-14	1998-12-08	La Region Wallone	Human myeloperoxidase and its therapeutic application
US5460961A (en) *	1988-06-14	1995-10-24	La Region Wallonne	Human myeloperoxidase and its therapeutic application
US5681566A (en) *	1988-10-24	1997-10-28	3I Research Exploitation Limited	Antibody conjugates with two or more covalently linked FC regions
US6685941B1 (en)	1988-11-23	2004-02-03	The Regents Of The University Of Michigan	Methods of treating autoimmune disease via CTLA-4Ig
AU6290090A (en) *	1989-08-29	1991-04-08	University Of Southampton	Bi-or trispecific (fab)3 or (fab)4 conjugates
US5378815A (en) *	1989-10-20	1995-01-03	National Research Council Canada	Process for indirect targeted immunocytolysis
ATE168272T1 (de) *	1989-10-27	1998-08-15	Arch Dev Corp	Zusammensetzungen und deren verwendung zur förderung der immunopotentiation
US6406696B1 (en)	1989-10-27	2002-06-18	Tolerance Therapeutics, Inc.	Methods of stimulating the immune system with anti-CD3 antibodies
US5273743A (en) *	1990-03-09	1993-12-28	Hybritech Incorporated	Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
IL97459A0 (en) *	1990-03-09	1992-06-21	Hybritech Inc	Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
JPH05268986A (ja) *	1990-03-19	1993-10-19	Bristol Myers Squibb Co	モノクローナル抗体及びリンパ球の活性法
GB9021679D0 (en) *	1990-10-05	1990-11-21	Gorman Scott David	Antibody preparation
US5872222A (en) *	1991-04-19	1999-02-16	Tanox Biosystems, Inc.	Conjugates of polymers and antibodies specific for T lymphocytes, and their use as adjuvants
CA2065658A1 (en) *	1991-04-19	1992-10-20	Tse-Wen Chang	Conjugates of liposomes or microbeads and antibodies specific for t lymphocytes and their use in vivo immune modulators
US6129916A (en) *	1991-04-19	2000-10-10	Tanox, Inc.	Method of Increasing activation on proliferation of T cells using antibody-microbead conjugates
US6197298B1 (en)	1991-04-19	2001-03-06	Tanox, Inc.	Modified binding molecules specific for T lymphocytes and their use as in vivo immune modulators in animals
US6106835A (en) *	1991-04-19	2000-08-22	Tanox, Inc.	Modified binding molecules specific for T or B lymphocytes and their use as in vivo immune modulators
IE922233A1 (en) *	1991-07-10	1993-01-13	Augusto C Ochoa	Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity
GB9206422D0 (en) *	1992-03-24	1992-05-06	Bolt Sarah L	Antibody preparation
ATE173543T1 (de) *	1992-04-10	1998-12-15	Thomas Totterman	Verfahren zum nachweis einer cmv-infektion
US5635602A (en) *	1993-08-13	1997-06-03	The Regents Of The University Of California	Design and synthesis of bispecific DNA-antibody conjugates
WO1995030014A1 (en)	1994-05-02	1995-11-09	Ciba-Geigy Ag	Bifunctional protein, preparation and use
DE4421391C1 (de) *	1994-06-18	1995-11-30	Gsf Forschungszentrum Umwelt	Verwendung von Antikörpern gegen T-Zellen zur verlängerten Immunsuppression
EP0945139A1 (en) *	1998-03-23	1999-09-29	Katholieke Universiteit Nijmegen	Methods and means for the treatment of immune related diseases such as Graft vs. Host disease
WO2000078348A1 (en) *	1999-06-17	2000-12-28	University Of Vermont And State Agricultural College	Autologous adoptive immunotherapy with primed antigen-specific t cells or b cells
US7541184B2 (en)	2000-02-24	2009-06-02	Invitrogen Corporation	Activation and expansion of cells
US7572631B2 (en)	2000-02-24	2009-08-11	Invitrogen Corporation	Activation and expansion of T cells
DE10034607A1 (de)	2000-07-20	2002-02-07	Gundram Jung	Multispezifisches Reagenz zur selektiven Stimulierung von Zelloberflächenrezeptoren
DE60231316D1 (de) *	2001-10-12	2009-04-09	Schering Corp	VERWENDUNG VON BISPEZIFISCHEN ANTIKÖRPERN GEGEN EINEN AKTIVIERENDEN REZEPTOR FcEpsilonRI UND GEGEN EINEN INHIBIERENDEN REZEPTOR OX2Ra (CD200Ra) ZUR REGULIERUNG DER IMMUNANTWORTEN
GB0305702D0 (en) *	2003-03-12	2003-04-16	Univ Birmingham	Bispecific antibodies
KR20250156861A (ko)	2019-05-21	2025-11-03	노파르티스 아게	Cd19 결합 분자 및 이의 용도
WO2021160267A1 (en) *	2020-02-13	2021-08-19	UCB Biopharma SRL	Bispecific antibodies against cd9 and cd7
EP4378529A1 (en) *	2022-12-03	2024-06-05	Universitätsklinikum Hamburg-Eppendorf	Antibody for use in a therapy involving effector cell engagement

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4381292A (en) *	1980-11-14	1983-04-26	The Board Of Trustees Of The Leland Stanford Jr. University	Anti-human T-lymphocyte monoclonal antibody
EP0153871A3 (en) *	1984-03-01	1987-07-01	Centocor, Inc.	Antibody enhancement of immunogenicity of antigen
JPH0617909B2 (ja) *	1984-04-23	1994-03-09	ボストンバイオメディカルリサーチインスティテュート，インコーポレイテッド	双特異性抗体決定子
GB8605316D0 (en) *	1986-03-04	1986-04-09	Royal Free Hosp School Med	Immunosuppression
JP2635343B2 (ja) *	1986-04-14	1997-07-30	ザ・ジェネラル・ホスピタル・コーポレーション	ヘテロ二官能性抗体および利用方法
GB8626412D0 (en) *	1986-11-05	1986-12-03	Clark M R	Antibodies
CA1338518C (en) *	1987-09-23	1996-08-13	Joyce M. Zarling	Antibody heteroconjugates for the killing of hiv-infected cells

1989
- 1989-03-30 FI FI891528A patent/FI105320B/fi not_active IP Right Cessation
- 1989-03-31 NO NO891375A patent/NO178699C/no not_active IP Right Cessation
- 1989-03-31 NZ NZ228560A patent/NZ228560A/xx unknown
- 1989-03-31 HU HU891607A patent/HU213576B/hu unknown
- 1989-04-03 DK DK198901594A patent/DK173382B1/da not_active IP Right Cessation
- 1989-04-03 IE IE105489A patent/IE72187B1/en not_active IP Right Cessation
- 1989-04-03 CN CN89101965A patent/CN1058296C/zh not_active Expired - Lifetime
- 1989-04-03 MY MYPI89000419A patent/MY106592A/en unknown
- 1989-04-03 ZA ZA892448A patent/ZA892448B/xx unknown
- 1989-04-03 IL IL8982389A patent/IL89823A/en not_active IP Right Cessation
- 1989-04-04 PT PT90195A patent/PT90195B/pt not_active IP Right Cessation
- 1989-04-04 JP JP1084148A patent/JP2613106B2/ja not_active Expired - Fee Related
- 1989-04-04 KR KR1019890004473A patent/KR100205833B1/ko not_active Expired - Fee Related
- 1989-04-04 AT AT89105907T patent/ATE133866T1/de not_active IP Right Cessation
- 1989-04-04 YU YU00685/89A patent/YU68589A/xx unknown
- 1989-04-04 EP EP89105907A patent/EP0336379B1/en not_active Expired - Lifetime
- 1989-04-04 AU AU32423/89A patent/AU629204B2/en not_active Expired
- 1989-04-04 DE DE68925593T patent/DE68925593T2/de not_active Expired - Lifetime
- 1989-04-04 ES ES89105907T patent/ES2083960T3/es not_active Expired - Lifetime
1996
- 1996-03-06 GR GR960400631T patent/GR3019224T3/el unknown

Also Published As

Publication number	Publication date
DK173382B1 (da)	2000-09-11
NZ228560A (en)	1991-10-25
IL89823A0 (en)	1989-12-15
MY106592A (en)	1995-06-30
DE68925593D1 (de)	1996-03-21
KR890015751A (ko)	1989-11-25
CN1058296C (zh)	2000-11-08
ES2083960T3 (es)	1996-05-01
IE891054L (en)	1989-10-04
YU68589A (en)	1991-10-31
EP0336379B1 (en)	1996-02-07
EP0336379A2 (en)	1989-10-11
GR3019224T3 (en)	1996-06-30
EP0336379A3 (en)	1990-01-31
FI105320B (fi)	2000-07-31
NO178699B (no)	1996-02-05
AU629204B2 (en)	1992-10-01
KR100205833B1 (ko)	1999-07-01
JPH01304356A (ja)	1989-12-07
DE68925593T2 (de)	1996-06-13
JP2613106B2 (ja)	1997-05-21
NO891375D0 (no)	1989-03-31
IE72187B1 (en)	1997-03-26
NO178699C (no)	1996-05-15
FI891528A0 (fi)	1989-03-30
HU213576B (en)	1997-08-28
PT90195A (pt)	1989-11-10
NO891375L (no)	1989-10-05
ATE133866T1 (de)	1996-02-15
IL89823A (en)	1994-07-31
CN1036988A (zh)	1989-11-08
DK159489A (da)	1989-10-05
AU3242389A (en)	1989-10-05
PT90195B (pt)	1994-06-30
DK159489D0 (da)	1989-04-03
ZA892448B (en)	1989-12-27
HUT51338A (en)	1990-04-28

Publication	Publication Date	Title
FI892718A0 (fi)	1989-06-02	Foerfarande foer framstaellning av farmaceutiska kompositioner foer anvaendning vid behandling av alkoholism.
FI891626A0 (fi)	1989-04-05	Foerfarande foer framstaellning av vid sedelframstaellning laemplig pappersmassa.
FI891528L (fi)	1989-10-05	Antikroppheterokonjugat foer anvaendning vid reglering av lymfocytaktivitet.
FI891336L (fi)	1989-09-22	Anordning vid en foerpackningsmaskin.
FI892361L (fi)	1989-11-20	Stoedkonstruktion foer fixering av en sanitetsanordning vid en konsol.
FI891128A7 (fi)	1989-09-13	Matningsbomanordning vid bergsborr.
FI885161L (fi)	1990-05-10	Arrangemang vid dubbelriktad telefonfoerbindelse.
FI885695A7 (fi)	1990-06-09	Slang- och kabeltrumanordning vid bergborrningsanordning.
FI893232L (fi)	1990-01-07	Foerfarande foer reglering av tillsats av retentionsmedel vid pappersframstaellning.
FI880226A0 (fi)	1988-01-20	Foerfarande foer kontroll av ligninets upploesning vid alkaliska massakok.
FI882685A0 (fi)	1988-06-07	Anordning vid intrakavitaer roentgenterapi avsedd foer behandling av elakartade aendtarmstumoerer.
FI894122L (fi)	1990-03-06	Fyllroer vid foerpackningsmaskin.
FI884000A0 (fi)	1988-08-31	Vid hjul gripande foerflyttningsanordning.
FI885616A0 (fi)	1988-12-02	Foerfarande foer raettande av maetningsfel vid vaetskescintillationsraekning.
FI884843L (fi)	1990-04-21	Foerfarande foer framstaellning av en pigmentblandning foer bruk vid ytbelaeggning av papper.
FI881958A0 (fi)	1988-04-26	Arrangemang vid faestandet av banskenor till staolsyllar.
FI903238A0 (fi)	1990-06-27	Golvplatta vid torkanordningar foer torkning av bulkgods.
FI883509A0 (fi)	1988-07-26	Anordning vid golvbrunn.
FI884475A0 (fi)	1988-09-29	Anordning vid belysningsarmatur.
FI892696L (fi)	1989-12-22	Foerfarande foer effektivering av stycketorvstorkning vid faelttorkning.
FI885696A7 (fi)	1990-06-09	Anordning foer styrning av slangar vid en bergborrningsanordning.
FI882970A7 (fi)	1989-12-22	Foerfarande foer effektivering av torkning av stycketorv vid faelttorkning.
FI880187A0 (fi)	1988-01-15	Utnyttjande av torkningsaonga vid energialstring.
FI911190A0 (fi)	1991-03-11	Materialkomprimeringsanordning foer anvaendning vid tillverkning av styva staenger.
FI911078A0 (fi)	1991-03-04	Foerkorrigeringsupphettningssteg vid behandling av litografisk tryckplatta.

Legal Events

Date	Code	Title	Description
2004-08-31	FG	Patent granted	Owner name: ONCOGEN
2009-04-17	MA	Patent expired